Percutaneous nephrostomy catheters is a widely used medical procedure in which a small, flexible rubber tube or catheter is inserted through the skin into the kidney to drain the urine while using imaging as a guide. This procedure helps decompress any ureteral obstruction in the renal collection system, which affects the normal flow of urine. percutaneous nephrostomy catheters (PCN) is a clinical intervention to remove kidney stones and to help the urinary tract function normally. Moreover, this procedure has fewer side effects than surgery, making it the best option for patients who do not want to have surgery or high-risk patients.Thus, the growing popularity of PCN procedures will fuel the demand for Percutaneous nephrostomy catheters during the forecast period.
High incidence and prevalence of chronic kidney diseases, rise in cases of urinary stones & urinary tract infections, coupled with rapidly rising rapidly as baby boomer population are some of the major factors anticipated to drive the Percutaneous Nephrostomy Catheters Market growth globally. As per the study published by the National Centre for Biotechnology Information (NCBI), in 2018, an estimated 12% of the Indian population is suffering from urolithiasis and out of which 50% may end up with a loss of kidney functions and urethral obstructions. Similarly, it is estimated that around 600,000 people in the U.S. suffer from urinary stones every year, which represents 1 in 11 people suffering from kidney stone. All these aforementioned factors are expected to boost the sale of Percutaneous nephrostomy catheters over the forecast period. PCN offers various advantages such as reduced hospital stay, smaller incision, shorter recovery time, and others owing to which the preference for these catheters are increasing globally.
Furthermore, product innovations, and increasing demand for accurate analysis for better clinical outcomes and extensive R&D activities by key participants are anticipated to drive the market toward growth further. For instance,
In May 2022, biotech specialist UroGen Pharma Ltd., highlights new data on real-world experience of an antegrade approach via a nephrostomy tube to administer JELMYTO for pyelocyte solution. These data add to the growing body of evidence regarding the safety and efficacy profile of JELMYTO's antegrade route of administration. These data were presented in a panel presentation at the 2022 American Urological Association (AUA) Annual Meeting in New Orleans.
These technological advancements are expected to boost the Percutaneous Nephrostomy Catheters Market growth over forecast period. However, risk of infection from catheters, and alternative treatment options for kidney and urinary diseases are expected to obstruct the market growth.
Some of the prominent players in the Percutaneous Nephrostomy Catheters Market include Boston Scientific Corporation, Cook, Coloplast Ltd., UROMED Kurt Drews KG, Create Medic, BD, Amecath, Telefex Incorporated, Bentec Medical, among others.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."